XIAP-associated factor 1 (XAF1) suppresses angiogenesis in mouse endothelial cells

Tumor Biology

Volumn 29, Issue 2, 2008, Pages 122-129

  Qiao, Liang ^a   Gu, Qing ^a   Dai, Yun ^a,b   Shen, Zan ^a   Liu, Xinyuan ^c   Qi, Rong ^c   Ma, Juan ^a   Zou, Bing ^a   Li, Zesong ^a   Lan, Hui Y ^a   Wong, Benjamin C Y ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b PEKING UNIVERSITY FIRST HOSPITAL   (China)

^c INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

Author keywords

Angiogenesis; Apoptosis; Endothelial cells; XAF1

Indexed keywords

ADENOVIRUS VECTOR; FLUOROURACIL; MYC PROTEIN; PROTEIN XAF 1; TIE 1 RECEPTOR; TUMOR SUPPRESSOR PROTEIN;

ANGIOGENESIS; ANIMAL CELL; APOPTOSIS; ARTICLE; ASSAY; CELL LINE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; INFECTION; MOUSE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSITIZATION; UPREGULATION; WOUND HEALING;

EID: 47949129803     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1159/000137831     Document Type: Article

References (23)

1. Papetti M, Herman IM: Mechanisms of normal and tumor-derived angiogenesis. Am J Physiol Cell Physiol 2002;282:C947-C970.
2. Hicklin DJ, Ellis LM: Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. J Clin Oncol 2005;23:1011-1027.
3. Tran J, Rak J, Sheehan C, Saibil SD, LaCasse E, Korneluk RG, Kerbel RS: Marked induction of the IAP family antiapoptotic proteins survivin and XIAP by VEGF in vascular endothelial cells. Biochem Biophys Res Commun 1999;264:781-788.
4. Byun DS, Cho K, Ryu BK, Lee MG, Kang MJ, Kim HR, Chi SG: Hypermethylation of XIAP-associated factor 1, a putative tumor suppressor gene from the 17p13.2 locus, in human gastric adenocarcinomas. Cancer Res 2003;63:7068-7075.
5. Liston P, Fong WG, Kelly NL, Toji S, Miyazaki T, Conte D, Tamai K, Craig CG, McBurney MW, Korneluk RG: Identification of XAF1 as an antagonist of XIAP anti-caspase activity. Nat Cell Biol 2001;3:128-133.
6. Wang JD, Peng Y, Sun YW, He H, Zhu SL, An XM, Li M, Lin MCM, Zou B, Xia HHX, Jiang B, Chan AOO, Yuen MF, Kung HF, Wong BCY: All-trans retinoic acid induces XAF1 expression through an interferon regulatory factor-1 element in colon cancer. Gastroenterology 2006;130:747-758.
7. Qi R, Gu J, Zhang Z, Yang K, Li B, Fan J, Wang C, He Z, Qiao L, Lin Z, Liu XY: Potent antitumor efficacy of XAF1 delivered by conditionally replicative adenovirus vector via caspase-independent apoptosis. Cancer Gene Ther 2007;14:82-90.
8. Zou B, Chim CS, Zeng H, Leung SY, Yang Y, Tu SP, Lin MC, Wang J, He H, Jiang SH, Sun YW, Yu LF, Yuen ST, Kung HF, Wong BC: Correlation between the single-site CpG methylation and expression silencing of the XAF1 gene in human gastric and colon cancers. Gastroenterology 2006;131:1835-1843.
9. Qiao L, Yu J, Dent P, Farrell G: NF-κB protects rat ARL-6 hepatocellular carcinoma cells against hydrogen peroxide-induced apoptosis. Cancer Biol Ther 2005;4:1195-1202.
10. Kwak HJ, So JN, Lee SJ, Kim I, Koh GY: Ang-1 is an apoptosis survival factor for endothelial cells. FEBS Lett 1999;448:249-253.
11. Stratmann A, Risau W, Plate KH: Cell type specific expression of Ang-1 and Ang-2 suggests a role in glioblastoma angiogenesis. Am J Pathol 1998;3:1459-1466.
12. Takahama M, Tsutsumi M, Tsujiuchi T, Nezu K, Kushibe K, Taniguchi K, Kotake Y, and Konishi Y: Enhanced expression of Tie2, its ligand Ang-1, vascular endothelial growth factor, and CD31 in human non-small cell lung carcinomas. Clin Cancer Res 1999;5:2506-2510.
13. Nguyen VP, Chen SH, Trinh J, Kim H, Coomber BL, Dumont DJ: Differential response of lymphatic, venous and arterial endothelial cells to angiopoietin-1 and angiopoietin-2. BMC Cell Biol 2007;8:10.
14. Sato TN, Tozawa Y, Deutsch U, Wolburg-Buchholz K, Fujiwara Y, Gendron-Maguire M, Gridley T, Wolburg H, Risau W, Qin Y, Sato TN, Tozawa Y, Deutsch U: Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 1995;376;70-74.
15. Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, Radziejewski C, Compton D, McClain J, Aldrich TH, Papadopoulos N, Daly TJ, Davis S, Sato TN, Yancopoulos GD: Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 1997;277:55-60.
16. Affara NI, Robertson FM: Vascular endothelial growth factor as a survival factor in tumor-associated angiogenesis. In vivo 2004;18:525-542.
17. Eisenman RN: Deconstructing myc. Genes Dev 2001;15:2023-2030.
18. Baudino TA, McKay C, Pendeville-Samain H, Nilsson JA, Maclean KH, White EL, Davis AC, Ihle JN, Cleveland JL: c-Myc is essential for vasculogenesis and angiogenesis during development and tumor progression. Genes Dev 2002;16:2530-2543.
19. Shchors K, Shchors E, Rostker F, Lawlor ER, Brown-Swigart L, Evan GI: The Myc-dependent angiogenic switch in tumors is mediated by interleukin 1β. Genes Dev 2006;20:2527-2538.
20. Dews M, Homayouni A, Yu D, Murphy D, Sevignani C, Wentzel E, Furth EE, Lee WM, Enders GH, Mendell JT, Thomas-Tikhonenko A: Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster. Nat Genet 2006;38: 1060-1065.
21. von Rahden BH, Stein HJ, Puhringer-Oppermann F, Sarbia M: c-myc amplification is frequent in esophageal adenocarcinoma and correlated with the upregulation of VEGF-A expression. Neoplasia 2006;8:702-707.
22. Bertl E, Bartsch H, Gerhäuser C: Inhibition of angiogenesis and endothelial cell functions are novel sulforaphane-mediated mechanisms in chemoprevention. Mol Cancer Ther 2006;5: 575-585.
23. Aref S, Mabed M, Zalata K, Sakrana M, El Askalany H: The interplay between c-Myc oncogene expression and circulating vascular endothelial growth factor (sVEGF), its antagonist receptor, soluble Flt-1 in diffuse large B cell lymphoma (DLBCL): relationship to patient outcome. Leuk Lymphoma 2004;45:499-506.